Digital health market: $573B by 2030

MarketsandMarkets’ forecast that the digital‑health market will jump from roughly USD 199.14 billion in 2025 to USD 573.53 billion by 2030 at a 23.6% CAGR names wearables, telehealth/RPM, digital therapeutics and rapid AI integration as the core segments driving that expansion. (marketsandmarkets.com) CB Insights’ State of Digital Health notes AI-focused companies captured a record share of dollars in 2024—about 42% of digital‑health funding—and accounted for roughly 31% of deals, making AI the sector’s largest investor magnet amid a broader pullback. (cbinsights.com) Rock Health reported U.S. digital‑health venture funding of about $10.1 billion in 2024 and describes a clear investor shift toward earlier‑stage checks (Seed–Series B) even as total deal sizes for later stages compressed. (fiercehealthcare.com) Apple’s HealthKit remains the iOS hub for health data and requires explicit user permissions and HealthKit entitlements to read or write defined clinical and activity data types such as sleep, heart rate and workout metrics. (developer.apple.com) Fitbit’s public Web API exposes intraday heart‑rate and activity time‑series endpoints with OAuth2 auth for per‑user access, while Oura and WHOOP publish OAuth2‑based cloud APIs and developer portals for sleep, readiness and recovery metrics (Oura’s API V2 is the current integration point and Oura limits unapproved apps to small user counts until approved). (dev.fitbit.com) HHS/OCR guidance and HIPAA’s statutory scope mean many consumer wellness apps are not automatically covered by HIPAA unless they operate as a “covered entity” or business associate, so regulation and compliance posture must be evaluated per business model. (hhs.gov) At the state level, California’s CPRA (effective 2023) expanded “sensitive personal information” to include health‑related data and added consumer rights like correction and limits on use, increasing compliance obligations for consumer health startups operating or serving Californians. (oag.ca.gov) Regulatory and reputational risk is tangible: Flo settled FTC allegations in 2021 over undisclosed data sharing and more recent class‑action settlements and enforcement activity have produced multi‑million dollar resolutions tied to health‑data disclosures. (ftc.gov) Patient advocacy platforms and condition‑specific registries show what chronic communities prioritize: CreakyJoints’ ArthritisPower relaunched after patient interviews and now includes tens of thousands of consented users tracking symptoms for clinical and research use. (digitalmedianet.com) Symptom‑tracking consumer apps such as Bearable and Flaredown advertise features patients repeatedly request in forums—customizable symptom lists, exportable longitudinal reports for clinicians, medication and trigger logging, and low‑cognitive‑load UIs for “brain fog” days. (bearable.app) Market leaders illustrate acquisition and retention playbooks: Noom scaled via a psychology‑based curriculum plus human coaching and raised a $540M growth round in 2021 as it leaned on subscription revenue and targeted paid acquisition. (businesswire.com) Headspace expanded reach by merging with on‑demand mental‑health provider Ginger to form Headspace Health (a deal valuing the combined company near $3 billion) and sustained retention with employer partnerships and B2B licensing in addition to consumer subscriptions. (techcrunch.com) Investors are underwriting early‑stage digital‑health founders but expect disciplined metrics: Rock Health’s 2024 analysis highlights growing early‑stage activity and tighter diligence on clinical validation, revenue channels and regulatory pathways. (rockhealth.com) VC‑oriented playbooks and founder content from a16z and startup guides recommend solo technical founders close early product‑market fit with measurable retention signals, consider adding complementary co‑founders for GTM and clinical credibility, and prepare concise evidence of outcomes when approaching digital‑health investors. (speedrun.substack.com)